Artiva to End Cell Therapy After Two Patient Deaths, Cut Workforce 94%
Artiva will discontinue its cell therapy program and cut its workforce by 94% after two patient deaths.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.